Key Takeaways
- MEM-ANT3310 and radiprodil, from Antabio and GRIN Therapeutics respectively, are the latest investigational products to make it onto the European Medicines priority medicines (PRIME) scheme.
MEM-ANT3310, which Antabio is developing to address antimicrobial resistance (AMR) in severe hospital infections, is among the latest products to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?